Study details
Enrolling now
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard
TherOx
NCT IDNCT04743245ClinicalTrials.gov data as of Apr 2026
Target enrollment
434
Study length
about 3.7 years
Ages
18+
Locations
1 site in MA
What this study is about
This trial is testing a new treatment, Delivery SSO2 therapy, given through a device (TherOx DownStream System) to patients who have had a heart attack (anterior MI). It compares this new treatment to standard care for these patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use PCI
- 2.Use TherOx DownStream System
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Cardiology / Heart